These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29306122)

  • 1. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.
    Bartoli-Abdou JK; Patel JP; Crawshaw J; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
    Thromb Res; 2018 Feb; 162():62-68. PubMed ID: 29306122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study.
    Bartoli-Abdou JK; Patel JP; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
    Thromb Res; 2021 Dec; 208():162-169. PubMed ID: 34801919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
    Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
    Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it reasonable to use a lower DOAC dose in some patients with VTE? NO.
    Dentali F; Fantoni C
    Intern Emerg Med; 2017 Aug; 12(5):565-567. PubMed ID: 28656545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
    Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin.
    Pundi KN; Perino AC; Fan J; Schmitt S; Kothari M; Szummer K; Askari M; Heidenreich PA; Turakhia MP
    J Am Heart Assoc; 2021 Dec; 10(23):e020904. PubMed ID: 34779243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges and future prospects in oral anticoagulant therapy.
    Czuprynska J; Patel JP; Arya R
    Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale.
    Castellucci LA; Shaw J; van der Salm K; Erkens P; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2015 Oct; 136(4):727-31. PubMed ID: 26272305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.
    Manzoor BS; Walton SM; Sharp LK; Galanter WL; Lee TA; Nutescu EA
    J Thromb Thrombolysis; 2017 Nov; 44(4):435-441. PubMed ID: 29027097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation prescribing patterns in patients with cancer.
    Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
    J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anticoagulation selection for acute venous thromboembolism.
    Badreldin H; Nichols H; Rimsans J; Carter D
    J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy.
    Patel SI; Cherington C; Scherber R; Barr K; McLemore R; Morisky DE; Cha S; Mookadam F; Shamoun F
    J Am Osteopath Assoc; 2017 Jan; 117(1):7-15. PubMed ID: 28055097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing patient preferences for switching from warfarin to direct oral anticoagulants.
    Wright JN; Vazquez SR; Kim K; Jones AE; Witt DM
    J Thromb Thrombolysis; 2019 Nov; 48(4):596-602. PubMed ID: 31273515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Time in Therapeutic Range Within a Warfarin Anticoagulation Clinic Following Introduction of Direct Oral Anticoagulants.
    Samuel P; Cassidy K; Lazarevskiy P; Cope R
    J Pharm Pract; 2024 Dec; 37(6):1311-1317. PubMed ID: 38797753
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism.
    Lim HY; Nandurkar H; Ho P
    Semin Thromb Hemost; 2018 Apr; 44(3):261-266. PubMed ID: 29558778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant.
    Minhas AS; Jiang Q; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; Froehlich JB; Barnes GD
    J Thromb Thrombolysis; 2016 Nov; 42(4):566-72. PubMed ID: 27217043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.